Trials / Completed
CompletedNCT00103818
An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)
A Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Efficacy Study of MK0928 15 mg and 10 mg in the Treatment of Adult Outpatients With Primary Insomnia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 900 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of MK0928 for insomnia (a sleep disorder).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gaboxadol | Duration of Treatment: 3 months |
| DRUG | Comparator: placebo (unspecified) | Duration of Treatment: 3 months |
Timeline
- Start date
- 2005-02-01
- Completion
- 2006-10-01
- First posted
- 2005-02-16
- Last updated
- 2015-01-14
Source: ClinicalTrials.gov record NCT00103818. Inclusion in this directory is not an endorsement.